Literature DB >> 2510591

Contribution of permeability and sensitivity to inhibition of DNA synthesis in determining susceptibilities of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis to ciprofloxacin.

J Bedard1, S Chamberland, S Wong, T Schollaardt, L E Bryan.   

Abstract

To examine the correlation between bacterial cell susceptibility to ciprofloxacin and the magnitude of uptake and cell target sensitivity, the relative contribution of ciprofloxacin accumulation in intact cells and its ability to inhibit DNA synthesis were investigated among strains of Escherichia coli, Pseudomonas aeruginosa, and Alcaligenes faecalis. Uptake studies of [14C]ciprofloxacin demonstrated diffusion kinetics for P. aeruginosa and E. coli. Ciprofloxacin was more readily removed from E. coli J53 and A. faecalis ATCC 19018 by washing than from P. aeruginosa PAO503. These results indicate that the process of cell accumulation is different for P. aeruginosa in that the drug is firmly bound at an extracellular site. Whatever the washing conditions, A. faecalis accumulated less drug than either of the other two bacteria. Magnesium chloride (10 mM) caused a substantial decrease of ciprofloxacin accumulated and an increase in the MIC, depending upon the nature of the medium. The addition of carbonyl cyanide m-chlorophenylhydrazone caused a variable increase in drug accumulated, depending on the medium and the bacterial strain. The concentration of ciprofloxacin required to obtain 50% inhibition (ID50) of DNA synthesis for P. aeruginosa PAO503 and A. faecalis ATCC 19018 did not correlate with their corresponding MICs but did for E. coli J53. Treatment with EDTA decreased the ID50 of ciprofloxacin for P. aeruginosa PAO503 and its gyrA derivative by 5- and 2-fold, respectively, and decreased the ID50 for E. coli JB5R, a strain with a known decrease in OmpF, by 1.4-fold but did not decrease the ID50 for the normally susceptible E. coli J53. The ID(50) for P. aeruginosa obtained after EDTA treatment or in ether-permeabilized cells was higher than that obtained for the other two strains. The protonophore carbonyl cyanide m-chlorophenylhydrazone prevented killing by low ciprofloxacin concentrtaions, but sodium azide did not. The latter compound did not enhance killing in association with inhibition of a previously described energy-dependent efflux of ciprofloxacin susceptibility being the susceptibility to inhibition of DNA synthesis in E. coli, poor premeability associated with the small pore size of A. faecalis, and a combination of low permeability and reduced susceptibility of DNA synthesis to inhibition for P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2510591      PMCID: PMC172683          DOI: 10.1128/AAC.33.9.1457

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Accumulation of enoxacin by Escherichia coli and Bacillus subtilis.

Authors:  J Bedard; S Wong; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1987-09       Impact factor: 5.191

2.  Norfloxacin resistance in a clinical isolate of Escherichia coli.

Authors:  H Aoyama; K Sato; T Kato; K Hirai; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-10       Impact factor: 5.191

3.  Computer automated structure evaluation of quinolone antibacterial agents.

Authors:  G Klopman; O T Macina; M E Levinson; H S Rosenkranz
Journal:  Antimicrob Agents Chemother       Date:  1987-11       Impact factor: 5.191

4.  Quinolone/ureidopenicillin cross-resistance.

Authors:  L J Piddock; W J Wijnands; R Wise
Journal:  Lancet       Date:  1987-10-17       Impact factor: 79.321

5.  Mutations producing resistance to norfloxacin in Pseudomonas aeruginosa.

Authors:  K Hirai; S Suzue; T Irikura; S Iyobe; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1987-04       Impact factor: 5.191

6.  Bactericidal mechanisms of ofloxacin.

Authors:  C S Lewin; J T Smith
Journal:  J Antimicrob Chemother       Date:  1988-09       Impact factor: 5.790

7.  Clinical isolate of Citrobacter freundii highly resistant to new quinolones.

Authors:  H Aoyama; K Fujimaki; K Sato; T Fujii; M Inoue; K Hirai; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1988-06       Impact factor: 5.191

8.  Studies on the interaction of 4-quinolones with DNA by DNA unwinding experiments.

Authors:  S Tornaletti; A M Pedrini
Journal:  Biochim Biophys Acta       Date:  1988-03-31

9.  Size of diffusion pore of Alcaligenes faecalis.

Authors:  J Ishii; T Nakae
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

10.  Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.

Authors:  N J Robillard; A L Scarpa
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

View more
  14 in total

1.  Resistance to pefloxacin in Pseudomonas aeruginosa.

Authors:  M Michea-Hamzehpour; C Lucain; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

2.  Escherichia coli resistant to cephalosporins and quinolones is still susceptible to the cephalosporin-quinolone ester Ro 23-9424.

Authors:  J Pace; A Bertasso; N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

3.  Comparison of recalcitrance to ciprofloxacin and levofloxacin exhibited by Pseudomonas aeruginosa bofilms displaying rapid-transport characteristics.

Authors:  J D Vrany; P S Stewart; P A Suci
Journal:  Antimicrob Agents Chemother       Date:  1997-06       Impact factor: 5.191

4.  Identification of inhibitors for single-stranded DNA-binding proteins in eubacteria.

Authors:  Jason G Glanzer; Jennifer L Endres; Brendan M Byrne; Shengqin Liu; Kenneth W Bayles; Greg G Oakley
Journal:  J Antimicrob Chemother       Date:  2016-09-08       Impact factor: 5.790

Review 5.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

6.  Fluoroquinolone supersusceptibility mediated by outer membrane protein OprH overexpression in Pseudomonas aeruginosa: evidence for involvement of a nonporin pathway.

Authors:  M Young; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1992-11       Impact factor: 5.191

Review 7.  Mode of action of the new quinolones: new data.

Authors:  D C Hooper; J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

8.  Lack of effect of carbonyl cyanide m-chlorophenylhydrazone on KB-5246 accumulation by Staphylococcus aureus.

Authors:  Y Kotera; Y Inoue; M Ohashi; K Ito; M Inoue
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

9.  In vitro antibacterial activities of tosufloxacin against and uptake of tosufloxacin by outer membrane mutants of Escherichia coli, Proteus mirabilis, and Salmonella typhimurium.

Authors:  J Mitsuyama; Y Itoh; M Takahata; S Okamoto; T Yasuda
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

10.  Genetic definition of the substrate selectivity of outer membrane porin protein OprD of Pseudomonas aeruginosa.

Authors:  H Huang; R E Hancock
Journal:  J Bacteriol       Date:  1993-12       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.